Muutke küpsiste eelistusi

Pharmacologic Therapy of Ocular Disease 2017 ed. [Kõva köide]

Edited by , Edited by
  • Formaat: Hardback, 394 pages, kõrgus x laius: 235x155 mm, kaal: 7256 g, VIII, 394 p., 1 Hardback
  • Sari: Handbook of Experimental Pharmacology 242
  • Ilmumisaeg: 16-Jun-2017
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3319582887
  • ISBN-13: 9783319582887
Teised raamatud teemal:
  • Kõva köide
  • Hind: 280,32 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 329,79 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 394 pages, kõrgus x laius: 235x155 mm, kaal: 7256 g, VIII, 394 p., 1 Hardback
  • Sari: Handbook of Experimental Pharmacology 242
  • Ilmumisaeg: 16-Jun-2017
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3319582887
  • ISBN-13: 9783319582887
Teised raamatud teemal:
There have been major advancements in the pharmacologic treatment of eye diseases over the past decade. With newly discovered disease targets and novel approaches to deliver therapeutic compounds to the eye, patients are seeing improved outcomes. Not only are there better treatments for diseases where treatments existed, we now have effective therapy for previously untreatable and blinding eye disorders. This volume will cover the pharmacologic treatment of eye diseases from the front of the eye including eyelids, conjunctiva and cornea all the way back to the retina and optic nerve. The first section of the volume reviews general principles of ocular pharmacology, pharmacokinetics, pharmaceutical sciences, and drug delivery. In addition, the volume provides an up to date guide to the pharmacologic approach to the key eye diseases that threaten sight or ocular function.
Part I General Principles
Principles of Ocular Pharmacology
3(28)
Yong Park
Dorette Ellis
Brett Mueller
Dorota Stankowska
Thomas Yorio
Ocular Pharmacokinetics
31(26)
Chandrasekar Durairaj
Ocular Drug Delivery
57(40)
Burcin Yavuz
Uday B. Kompella
Part II Anterior Segment and Tear Film
Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis
97(22)
Shilpa Gulati
Sandeep Jain
Anti-Infective and Anti-Inflammatory Pharmacotherapies
119(18)
Mark I. Rosenblatt
Keratoconus and Other Corneal Diseases: Pharmacologic Cross-Linking and Future Therapy
137(26)
Kimberly M. Hsu
Joel Sugar
Lens: Management of Cataract Surgery, Cataract Prevention, and Floppy Iris Syndrome
163(18)
Joao Crispim
Wallace Chamon
Part III Trabecular Meshworkand Uvea
Glaucoma-Intraocular Pressure Reduction
181(28)
Alex S. Huang
Lilit Minasyan
Robert N. Weinreb
Translational Pharmacology in Glaucoma Neuroprotection
209(22)
Leonard A. Levin
Pharmacologic Treatment of Noninfectious Uveitis
231(40)
Jared E. Knickelbein
Karen R. Armbrust
Meredith Kim
H. Nida Sen
Robert B. Nussenblatt
Part IV Posterior Segment and Optic Nerve
Anti-angiogenic Therapy for Retinal Disease
271(38)
Yannis M. Paulus
Akrit Sodhi
Corticosteroids and Anti-Complement Therapy in Retinal Diseases
309(12)
Raja Narayanan
Baruch D. Kuppermann
Dry Age-Related Macular Degeneration Pharmacology
321(16)
Charles B. Wright
Jayakrishna Ambati
Hereditary Retinal Dystrophy
337(32)
Thomas C. Hohman
Optic Nerve
369(18)
Lynn K. Gordon
Index 387